Ezetimibe and Simvastatin
NDC 59651-835, Ezetimibe and Simvastatin, tablet, from Aurobindo Pharma Limited.
- Product NDC
- 59651-835
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA200082
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59651-835 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- EZETIMIBE10 mg/1
- SIMVASTATIN10 mg/1
Pharmacologic classes
Decreased Cholesterol Absorption [PE]; Dietary Cholesterol Absorption Inhibitor [EPC]; HMG-CoA Reductase Inhibitor [EPC]; Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59651-835-30 | 59651083530 | 30 TABLET in 1 BOTTLE (59651-835-30) |
| 59651-835-90 | 59651083590 | 90 TABLET in 1 BOTTLE (59651-835-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/79dadfde-35c7-4937-9c82-1728fb6be2fb
Use it
Look up 59651-835 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59651-835 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59651-835. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.